Liquidia Corp (LQDA)
12.74
+0.45
(+3.66%)
USD |
NASDAQ |
May 16, 16:00
12.72
-0.02
(-0.12%)
After-Hours: 20:00
Liquidia Free Cash Flow: -69.52M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -69.52M |
| December 31, 2023 | -52.85M |
| September 30, 2023 | -41.76M |
| June 30, 2023 | -25.59M |
| March 31, 2023 | -28.22M |
| December 31, 2022 | -29.18M |
| September 30, 2022 | -31.66M |
| June 30, 2022 | -31.63M |
| March 31, 2022 | -31.49M |
| December 31, 2021 | -34.14M |
| September 30, 2021 | -40.69M |
| June 30, 2021 | -47.49M |
| March 31, 2021 | -52.71M |
| Date | Value |
|---|---|
| December 31, 2020 | -54.90M |
| September 30, 2020 | -54.96M |
| June 30, 2020 | -54.92M |
| March 31, 2020 | -54.40M |
| December 31, 2019 | -50.13M |
| September 30, 2019 | -44.37M |
| June 30, 2019 | -38.20M |
| March 31, 2019 | -32.80M |
| December 31, 2018 | -32.70M |
| September 30, 2018 | -30.23M |
| June 30, 2018 | -30.10M |
| March 31, 2018 | -28.00M |
| December 31, 2017 | -26.83M |
Free Cash Flow Range, Past 5 Years
-69.52M
Minimum
Mar 2024
-25.59M
Maximum
Jun 2023
-43.44M
Average
-43.06M
Median
Free Cash Flow Benchmarks
| United Therapeutics Corp | 752.40M |
| AIM ImmunoTech Inc | -21.85M |
| Perspective Therapeutics Inc | -37.98M |
| Protalix BioTherapeutics Inc | 4.369M |
| Armata Pharmaceuticals Inc | -46.82M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -24.87M |
| Cash from Investing (Quarterly) | -0.624M |
| Cash from Financing (Quarterly) | 99.67M |
| Free Cash Flow Per Share (Quarterly) | -0.3381 |
| Free Cash Flow to Equity (Quarterly) | -25.49M |
| Free Cash Flow Yield | -8.06% |